TodayBuildContextBrowseMore
stackBETAv0.1
TodayBuild a stackCommon stacksEncyclopediaPulse
Methodology
← Back to your stack
Monograph
FDA APPROVEDP-058
Longevity

NAC (N-Acetyl Cysteine)

Glutathione precursor and cysteine donor. Primary antioxidant replenishment pathway. Also mucolytic and hepatoprotective. Widely used for liver protection, addiction recovery, and OCD adjunct therapy.

EstablishedLongevity
Typical dose600–1200 mg
Frequencydaily, oral
Half-life6h
Citations indexed2847
DeliveryOral
Half-life~6h
EvidenceEstablished
Citations2847
Similar compounds
Synergy checkCompare
Mechanism

NAC restores intracellular glutathione, the body's master antioxidant. FDA-approved as mucolytic and acetaminophen overdose antidote. Meta-analyses show meaningful benefit for COPD, psychiatric disorders (OCD, depression adjunct), and infertility. Longevity use is based on glutathione depletion with aging and mitochondrial oxidative stress theory.

Specifics
Cellular aging concernsMoodLow energy / fatigue
Caveats

GI upset at high doses — split into 2 doses. Sulfur smell is normal. May blunt some exercise adaptations (antioxidant paradox). Anticoagulant interaction at very high doses. Rare: bronchospasm with inhaled form.

Evidence levelEstablished
Regulatory statusFDA-approved drug (mucolytic/antidote). Also sold as supplement — FDA tried to remove supplement status 2020, backed off.
DNA / pharmacogenomicsLow — GSTM1 null variants (common) have lower glutathione capacity — may benefit most from supplementation.
Claims & evidence

Per-claim grading. Each claim is graded independently — same peptide, different claims can carry different grades.

  • BModerate evidence

    NAC (N-Acetyl Cysteine) — primary mechanism: glutathione precursor and cysteine donor. primary antioxidant replenishment pathway. also mucolytic and hepatoprotective. widely used for liver protection, addiction recovery, and ocd adjunct therapy.

    2 supporting referencesVerified 5d ago
References

External links to PubMed searches, ClinicalTrials.gov, and FDA materials. We do not host papers — we point at canonical sources.

  • PubMedEN
    REVIEWFunding undisclosedVerified 5d ago
    PubMed — NAC glutathione aging
  • PubMedEN
    REVIEWFunding undisclosedVerified 5d ago
    PubMed — NAC psychiatric RCTs
FDA APPROVEDP-058

FDA-approved drug (mucolytic/antidote). Also sold as supplement — FDA tried to remove supplement status 2020, backed off.

NAC600–1200 mg · daily, oral
Discussion guide, not prescription

stack is an exploration engine. Output is a discussion guide for a conversation with a licensed provider — never a prescription, dose recommendation, or sourcing instruction. Peptides discussed include compounds with limited human evidence and varying legal status by jurisdiction. Verify everything with a qualified clinician before any decision.

Full terms →
stackv0.1
AudiencesWho Stack is forFor researchersFor pharmaciesFor cliniciansFor press
Trust & regulatoryCalibrationMethodologyFDA statusPharmacy registryPCAC commentMX · COFEPRIS
Built honest. Bilingual from day one.